Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Who Will Join Us? EU Regulators Seek Feedback On Proposed Clinical Trials Discussion Platform

Executive Summary

Regulators want to know who is interested in joining their planned multi-stakeholder platform for discussions on how to improve clinical trials in Europe. They are also seeking feedback on which topics should be prioritized for discussion.

You may also be interested in...



EU Project To Evaluate Delays To Drug Trials Conducted Alongside Studies For IVDs/Devices

The European Commission is steering a new member state-driven project that aims to get to the bottom of factors causing delays to trials that simultaneously investigate a drug product with an IVD or a medical device, and propose some solutions.

EU Project To Evaluate Delays To Drug Trials Conducted In Combination With Studies For IVDs/Devices

The European Commission is steering a new member state driven project that aims to get to the bottom of factors causing delays to trials that simultaneously investigate a drug product with an IVD or a medical device, and propose some solutions.

EU Clinical Trials System Should Be Free Of Major Bugs Within Three Months

A senior executive at the European Medicines Agency says that all major technical problems with the EU Clinical Trials Information System are close to being resolved, and will free up time to focus on delivering much needed improvements and new functionalities.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS147689

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel